Iniciar sesión para ver los precios por organización y contrato.
Seleccione un Tamaño
Acerca de este artículo
Fórmula empírica (notación de Hill):
C7H17NO5
Número CAS:
Peso molecular:
195.21
UNSPSC Code:
12352104
NACRES:
NA.22
PubChem Substance ID:
EC Number:
228-506-9
Beilstein/REAXYS Number:
385906
MDL number:
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarleServicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarleInChI
1S/C7H17NO5/c1-8-2-4(10)6(12)7(13)5(11)3-9/h4-13H,2-3H2,1H3/t4-,5+,6+,7+/m0/s1
SMILES string
CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO
InChI key
MBBZMMPHUWSWHV-BDVNFPICSA-N
assay
99.0-100.5% (titration)
form
powder
autoignition temp.
~662 °F
mp
129-131.5 °C (lit.)
Quality Level
¿Está buscando productos similares? Visita Guía de comparación de productos
General description
N-Methyl-D-glucamine, also known as methylglucamine, is an organic compound that belongs to the class of amino sugars. It is commonly used in pharmaceutical and biochemical applications as a resolving and buffering agent. Salts of N-methyl-D-glucamine have also been used for X-ray contrast media and nuclear imaging agents.
Application
N-Methyl-D-glucamine (NMG) can be used as a reactant to prepare water-soluble polymer for the selective removal of arsenic from aqueous water. It is also used in the development of various resins and gels containing NMG to remove different oxyanions.
Clase de almacenamiento
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
Andrea Barison et al.
Journal of cardiovascular medicine (Hagerstown, Md.), 16(10), 681-687 (2015-06-20)
In nonischaemic dilated cardiomyopathy (NICM), replacement myocardial fibrosis as detected by late gadolinium enhancement (LGE) at cardiovascular magnetic resonance (CMR) is associated with poor prognosis. We investigated the as-yet unexplored prognostic significance of interstitial fibrosis in NICM, using T1-mapping CMR.
Alexander Radbruch et al.
Radiology, 275(3), 783-791 (2015-04-08)
To compare changes in signal intensity (SI) ratios of the dentate nucleus (DN) and the globus pallidus (GP) to those of other structures on unenhanced T1-weighted magnetic resonance (MR) images between linear and macrocyclic gadolinium-based contrast agents (GBCAs). The study
Ntobeko A B Ntusi et al.
JACC. Cardiovascular imaging, 8(5), 526-536 (2015-04-22)
The goal of this study was to assess the diffuse myocardial fibrosis and edema in rheumatoid arthritis (RA) using multiparametric cardiac magnetic resonance (CMR) and the association of myocardial T1 and extracellular volume (ECV) with disease activity, duration, and cardiac
Raphaëlle Renard-Penna et al.
Radiology, 275(2), 458-468 (2015-01-20)
To compare the diagnostic performance of the magnetic resonance (MR) imaging-based Prostate Imaging Reporting and Data System (PI-RADS) and a Likert scale in the detection of prostate cancer in a cohort of patients undergoing initial prostate biopsy. This institutional review
Isabelle Thomassin-Naggara et al.
Radiology, 267(2), 432-443 (2013-03-08)
To construct and undertake preliminary validation of a magnetic resonance (MR) imaging scoring system designed for use in pelvic MR imaging performed for characterization of adnexal masses that were indeterminate at ultrasonography (US). The institutional ethics committee approved this retrospective
Contenido relacionado
Product Information Sheet
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico